144 related articles for article (PubMed ID: 35648812)
1. Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
Jakielaszek C; Hossain M; Qian L; Fishman C; Widdowson K; Hilliard JJ; Mannino F; Raychaudhuri A; Carniel E; Demons S; Heine HS; Hershfield J; Russo R; Mega WM; Revelli D; O'Dwyer K
Sci Transl Med; 2022 Jun; 14(647):eabg1787. PubMed ID: 35648812
[TBL] [Abstract][Full Text] [Related]
2. The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal Rule.
Hewitt JA; Lanning LL; Campbell JL
Clin Infect Dis; 2020 May; 70(70 Suppl 1):S51-S59. PubMed ID: 32435803
[TBL] [Abstract][Full Text] [Related]
3. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
[TBL] [Abstract][Full Text] [Related]
4. Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague.
Campbell JL; Fay MP; Lanning LL; Hewitt JA
Clin Infect Dis; 2020 May; 70(70 Suppl 1):S60-S65. PubMed ID: 32435805
[TBL] [Abstract][Full Text] [Related]
5. Levofloxacin cures experimental pneumonic plague in African green monkeys.
Layton RC; Mega W; McDonald JD; Brasel TL; Barr EB; Gigliotti AP; Koster F
PLoS Negl Trop Dis; 2011 Feb; 5(2):e959. PubMed ID: 21347450
[TBL] [Abstract][Full Text] [Related]
6. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL
Antimicrob Agents Chemother; 2011 Feb; 55(2):822-30. PubMed ID: 21115791
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
Hilliard JJ; Jakielaszek C; Mannino F; Hossain M; Qian L; Fishman C; Demons S; Hershfield J; Soffler C; Russo R; Henning L; Novak J; O'Dwyer K
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0149723. PubMed ID: 38358266
[No Abstract] [Full Text] [Related]
8. Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge.
Jakielaszek C; Hilliard JJ; Mannino F; Hossain M; Qian L; Fishman C; Chou YL; Henning L; Novak J; Demons S; Hershfield J; O'Dwyer K
Antimicrob Agents Chemother; 2023 May; 67(5):e0138122. PubMed ID: 37097147
[TBL] [Abstract][Full Text] [Related]
9. Tn-Seq Analysis Identifies Genes Important for Yersinia pestis Adherence during Primary Pneumonic Plague.
Eichelberger KR; Sepúlveda VE; Ford J; Selitsky SR; Mieczkowski PA; Parker JS; Goldman WE
mSphere; 2020 Aug; 5(4):. PubMed ID: 32759339
[TBL] [Abstract][Full Text] [Related]
10. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
[TBL] [Abstract][Full Text] [Related]
11. Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague.
Nguyen D; Shaik JS; Tai G; Tiffany C; Perry C; Dumont E; Gardiner D; Barth A; Singh R; Hossain M
Br J Clin Pharmacol; 2022 Feb; 88(2):416-428. PubMed ID: 34289143
[TBL] [Abstract][Full Text] [Related]
12. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
13. Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak.
Andrianaivoarimanana V; Wagner DM; Birdsell DN; Nikolay B; Rakotoarimanana F; Randriantseheno LN; Vogler AJ; Sahl JW; Hall CM; Somprasong N; Cauchemez S; Schweizer HP; Razafimandimby H; Rogier C; Rajerison M
Clin Infect Dis; 2022 Mar; 74(4):695-702. PubMed ID: 34244722
[TBL] [Abstract][Full Text] [Related]
14. Interactions between Gepotidacin and
Oviatt AA; Gibson EG; Huang J; Mattern K; Neuman KC; Chan PF; Osheroff N
ACS Infect Dis; 2024 Apr; 10(4):1137-1151. PubMed ID: 38606465
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
[TBL] [Abstract][Full Text] [Related]
16. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague.
Welkos S; Pitt ML; Martinez M; Friedlander A; Vogel P; Tammariello R
Vaccine; 2002 May; 20(17-18):2206-14. PubMed ID: 12009274
[TBL] [Abstract][Full Text] [Related]
17. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.
Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK
Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK
Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803
[TBL] [Abstract][Full Text] [Related]
19.
Farrell DJ; Sader HS; Rhomberg PR; Scangarella-Oman NE; Flamm RK
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069643
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis.
Van Andel R; Sherwood R; Gennings C; Lyons CR; Hutt J; Gigliotti A; Barr E
Comp Med; 2008 Feb; 58(1):68-75. PubMed ID: 19793459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
